Best Practices for Treating Pain with Opioid Analgesics, 2nd Edition


About the Course: 
The purpose of this course is to provide the fundamentals of acute and chronic pain management and a contextual framework for the safer prescribing of opioid analgesics that includes consideration of a full complement of nonopioid treatment options. 

Learning Outcomes: 
Upon completion of the course, the learner will be able to:

  • Discuss pain and comorbidity assessments as appropriate to the individual patient and pain type and duration.
  • Discuss an individualized treatment plan utilizing or considering a full range of medication and nonmedication options.
  • Identify risk or presence of OUD before initiating or continuing opioid therapy for pain.
  • Recognize signs and symptoms of OUD, strategies for optimal management, and when to refer to a specialist.

About the Author/Presenter
Chadwick Rawana, MD
Professor, Fanshawe College

How to receive credit:

  • Read the entire course online or in print which requires a 2-hour commitment of time. 
  • After completion of the course, complete the final examination.  A passing grade of 70% is required. Test questions link content to learning outcomes as a method to enhance individualized learning and material retention. 
  • Note to Nursing professionals: Depending on your state requirements, you will be asked to either affirm that you have completed the course, or you will be required to complete the Post-test included in the course.
  • Provide required personal information and payment information.
  • Complete the mandatory course evaluation.
  • Print your Certificate of Completion.

In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, InforMed implemented mechanisms, prior to the planning and implementation of this CME activity, to identify and resolve conflicts of interest for all individuals in a position to control the content of this CME activity.

InforMed staff, input committee and all content validation reviewers involved with this activity have reported no relevant financial relationships with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

2024 All rights reserved. These materials, except those in the public domain, may not be reproduced without permission from InforMed. This publication is designed to provide general information prepared by professionals in regard to the subject matter covered. It is provided with the understanding that InforMed, Inc is not engaged in rendering legal, medical or other professional services. Although prepared by professionals, this publication should not be utilized as a substitute for professional services in specific situations. If legal advice, medical advice or other exper